Drusen in hereditary angioedema patients, aged 50 years and older.

Drusen in hereditary angioedema patients, aged 50 years and older. - Drusen in HAE patients.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32467

Enrollment

Registered

2010-03-05

Start date

2010-08-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drusen retinal waste depositions AND/OR age related macular degeneration

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with hereditairy angioedema, aged 50 years and older.

Exclusion criteria

Exclusion criteria: retinal pathology, other than drusen formation and/or age related macular degeneration.

Design outcomes

Primary

Measure	Time frame
The prevalence of AMD and/or drusen in HAE patients.	—

Secondary

Measure	Time frame
What kind of variations in the C1-inhibitor gene cause AMD and/or drusen.	—

Countries

Netherlands

Outcome results